METTL3 Drives NAFLD-Related Hepatocellular Carcinoma and Is a Therapeutic Target for Boosting Immunotherapy

Single-cell RNA sequencing revealed that METTL3 suppressed antitumor immune response by reducing granzyme B and interferon gamma-positive CD8+ T cell infiltration, thereby facilitating immune escape.